Your Waterstones card is changing, introducing...
TELL ME MORE
Enzyme- and Transporter-Based Drug-Drug Interactions: Progress and Future Challenges (Paperback)
  • Enzyme- and Transporter-Based Drug-Drug Interactions: Progress and Future Challenges (Paperback)
zoom

Enzyme- and Transporter-Based Drug-Drug Interactions: Progress and Future Challenges (Paperback)

(editor), (editor), (editor)
£149.99
Paperback 746 Pages / Published: 26/11/2014
  • We can order this

Usually despatched within 3 weeks

  • This item has been added to your basket

Germination of the thought of "Enzymatic- and Transporter-Based Drug-Drug Interactions: Progress and Future Challenges" Proceedings came about as part of the annual meeting of The American Association of Pharmaceutical Scientists (AAPS) that was held in San Diego in November of 2007. The attendance of workshop by more than 250 pharmaceutical scientists reflected the increased interest in the area of drug-drug interactions (DDIs), the greater focus of PhRMA, academia, and regulatory agencies, and the rapid pace of growth in knowledge. One of the aims of the workshop was to address the progress made in quantitatively predicting enzyme- and transporter-based DDIs as well as highlighted areas where such predictions are poor or areas that remain challenging for the future. Because of the serious clinical implications, initiatives have arisen from the FDA (http://www.fda.gov/cber/gdlns/interactstud.htm) to highlight the importance of enzyme- and transporter-based DDIs.

During the past ten to fifteen years, we have come to realize that transporters, in addition to enzymes, play a vital role in drug elimination. Such insight has been possible because of the continued growth in PK-ADME (pharmacokinetics-absorption-distribution-metabolism-excretion) knowledge, fueled by further advances in molecular biology, greater availability of human tissues, and the development of additional and sophisticated model systems and sensitive assay methods for studying drug metabolism and transport in vitro and in vivo. This has sparked an in-depth probing into mechanisms surrounding DDIs, resulting from ligand-induced changes in nuclear receptors, as well as alterations in transporter and enzyme expression and function. Despite such advances, the in vitro and in vivo study of drug interactions and the integration of various data sets remain challenging. Therefore, it has become apparent that a proceeding that serves to encapsulate current strategies, approaches, methods and applications is necessary.

As Editors, we have assembled a number of opinion leaders and asked them to contribute chapters surrounding these issues. Many of these are the original Workshop speakers whereas others had been selected specially to contribute on topics related to basic and applied information that had not been covered in other reference texts on DDI. The resulting tome, entitled Enzyme- and Transporter-Based Drug Interactions: Progress and Future Challenges, comprises of four sections. Twenty-eight chapters covering various topics and perspectives related to the subject of metabolic and transporter-based drug-drug interactions are presented.

Publisher: Springer-Verlag New York Inc.
ISBN: 9781489994899
Number of pages: 746
Weight: 1151 g
Dimensions: 235 x 155 x 39 mm
Edition: 2010 ed.

You may also be interested in...

Aromatherapy Lexicon
Added to basket
£4.99
Paperback
Heal Thyself
Added to basket
£4.99
Paperback
Psychiatric Drugs Explained
Added to basket
The Top 100 Drugs
Added to basket
Oxford Handbook of Practical Drug Therapy
Added to basket
Drugs in Palliative Care
Added to basket
Psychiatric Drug Withdrawal
Added to basket
Aromatherapy
Added to basket
£1.99
Paperback
Rang & Dale's Pharmacology
Added to basket
The Fragrant Mind
Added to basket

Reviews

Please sign in to write a review

Your review has been submitted successfully.